Activity Overview
The Training Rheum 2026 is a concise, virtual training program for advanced practice providers (APPs) new to rheumatology that combines online learning modules and access to an expert-led, recorded training session to educate APPs on comprehensive history and physical examinations for new patients; performing a disease-focused history and physical examination for established patients; formulating an appropriate differential diagnosis; ordering appropriate diagnostic testing and interpreting testing to create treatment plans; recognizing the impact of social determinants of health; discerning skin disease manifestations in diverse populations; and developing the ability to diagnose and manage rheumatic diseases in the rheumatology setting.
We recommend learners to complete activities prior to watching the expert -led training session.
Target Audience
Advanced practice providers (APPs) including both nurse practitioners and physician assistants, fellows in training, and pharmacists who are new to rheumatology.
Learning Objectives
Upon completion of this activity, participants should be able to:
Be versed in components of a history and physical examination for a new patient, including a detailed musculoskeletal examination, joint assessment, and joint injections
Be proficient with foundational components of a disease-focused history and physical examination for a follow-up patient, including musculoskeletal examination, joint assessment, and joint injections
Formulate an appropriate differential diagnosis
Order appropriate laboratory, radiographic examinations, and other diagnostic testing
Utilize and integrate results of laboratory, radiographic examinations, and other diagnostic testing into management plans under the supervision/collaboration of a rheumatologist
Recognize the impact of social determinants of health and health disparities on provision of care and disease self-management when providing healthcare to diverse communities and populations
Recognize skin manifestations in diverse patient populations/ skin of color
With appropriate supervision/collaboration, recognize and manage a number of rheumatic diseases in the adult and pediatric rheumatology clinic setting
Price
Member: $599
Nonmember: $799
If you are not a member, consider joining ACR/ARP.
CE & MOC Information
Credit must be claimed by March 24, 2029, at 11:59 PM ET.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
ACPE credits are reported to CPE Monitor monthly NABP e-PID and date of birth provided when you claimed credit and should appear in your CPE dashboard within 60 days of credit claiming.
All other credit types must be self-reported by the learner to the respective board. Your certificate is your record of credit.
All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity.
Available Credit
CME: 11.50 AMA PRA Category 1 Credit(s)™
AAPA: 11.50 AAPA Category 1 CME™ Credits
ACPE: 11.50 CPE Credits
ANCC: 11.50 Contact Hours
Designation Statements
Joint Accreditation
In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797
See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet.
AMA
The ACR designates this enduring activity for a maximum of 11.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA
The ACR has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 11.50 AAPA Category 1 CME credits. Approval is valid until March 24, 2029. PAs should only claim credit commensurate with the extent of their participation.
ACPE
The ACR designates this enduring activity for a maximum of 11.50 hours of ACPE contact hour(s). Pharmacists and pharmacy technicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit will be uploaded to the NABP CPE Monitor® within 60 days after activity completion. Per ACPE rules, ACR does not have access nor the ability to upload credits requested after the evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information (NABP ID and date of birth (MMDD)) to receive credit. The Universal Activity Number(s) for this activity is JA0003797-0000-26-001-H99-P.
All continuing pharmacy education credits must be claimed within 60 days of the enduring activity you attend. To be sure your CE is accepted inside of ACPE's 60-day window, plan to process your CE before March 24, 2029, at 11:59 PM ET. After the 60-day deadline, ACR will no longer be able to award credit for this activity.
ANCC
The ACR designates this activity for a maximum of 11.50 ANCC contact hours.CE & MOC Information
Financial Relationship Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
Advisor or review panel member
Consultant
Employee
Officer or Board Member
Grant/research support
Speaker/honoraria includes speaker’s bureau, symposia, and expert witness
Independent contractor
Executive role and/or ownership interest
Royalties and/or patent beneficiary
Intellectual property/patents
Stock options or bond holdings in a for-profit corporation or self-directed pension plan
Private investigator
Expert witness
Equity interest
Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. The Training Rheum 2026 Financial Relationship Disclosures
Acknowledgement of Commercial Support
No commercial support was provided for this activity.
Educational Activity Policies
See ACR educational activity policies, including the online enduring activity refund policy.